SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-21-045167
Filing Date
2021-02-16
Accepted
2021-02-16 17:06:12
Documents
3
Group Members
BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.BESSEMER VENTURE PARTNERS VII L.P.BVP VII SPECIAL OPPORTUNITY FUND L.P.DEER VII & CO. L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d122474dsc13ga.htm SC 13G/A 113435
2 EX-99.1 d122474dex991.htm EX-99.1 9452
3 EX-99.2 d122474dex992.htm EX-99.2 1811
  Complete submission text file 0001193125-21-045167.txt   126486
Mailing Address C/O BESSEMER VENTURE PARTNERS 1865 PALMER AVE LARCHMONT NY 10538
Business Address C/O BESSEMER VENTURE PARTNERS 1865 PALMER AVE LARCHMONT NY 10538 (914) 833-9100
Deer VII & Co. Ltd. (Filed by) CIK: 0001540726 (see all company filings)

IRS No.: 980539991 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Subject) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90175 | Film No.: 21640620
SIC: 2836 Biological Products, (No Diagnostic Substances)